Navigation Links
| HOME >> MEDICINE >> TECHNOLOGY |
Favrille Provides Update on Timing of Analysis from Pivotal Phase 3 Clinical Trial; Reports Third Quarter 2007 Financial Results
Date:10/25/2007
STATEMENTS OF CASH FLOWS
(in thousands)
Unaudited
Nine Months ended
September 30,
2007 2006
Operating activities
Net loss $(35,247) $(30,265)
Adjustments to reconcile net loss to
net cash used in operating activities:
Depreciation and amortization 2,361 1,534
Stock-based compensation 3,530 2,898
Amortization of premium/discount on
short-term investments (401) (428)
Other 83 294
Changes in operating assets and liabilities:
Other assets (237) (635)
Accounts payable and accrued liabilities (437) 1,915
Deferred rent 1,216 3,313
Net cash used in operating activities (29,132) (21,374)
Investing activities
Purchases of property and equipment (8,983) (8,461)
Purchases of short-term investments (11,337) (48,735)
Maturities of short-term investments 38,599 40,098
Restricted cash - (1,901)
Net cash provided by (used in)
investing activities 18,279 (18,999)
Financing activities
Proceeds from debt 6,884 4,822
Payments on debt (4,356) (2,103)
Issuance of common stock and warrants 13,644 45,449
'/>"/>
| SOURCE Favrille, Inc. Copyright©2007 PR Newswire. All rights reserved |
Related medicine technology :
1. Favrille Announces Data From Phase 2 Clinical Trial of FavId for Indolent B-Cell Non-Hodgkins Lymphoma in Europe
2. Favrille Announces Results From Study Showing Enhanced Activity From Insect Cell-Derived Immunotherapy for Lymphoma
3. Largest Cervical Cancer Vaccine Efficacy Trial Shows Cervarix Provides Excellent Protection Against Lesions Caused by Most Common Cancer-Causing Virus Types
4. Liraglutide provides significantly better glucose control than insulin glargine in phase 3 study
5. XTL Provides Update on Phase I Clinical Trial of XTL-2125
6. Cervarix, the GSK Cervical Cancer Candidate Vaccine, Provides Sustained Immune Response in 100 Percent of Women up to 55 Years of Age
7. Daytrana (methylphenidate transdermal system) Provides Significant Effectiveness in ADHD Symptom Relief in Both Boys and Girls
8. DURECT Provides an Update to the Memryte Program Under Development by Voyager Pharmaceutical Corp
9. NicOx Provides an Update on the Phase 2a Study for NCX 1000 Conducted With Axcan
10. Indivumed Study Provides Sound Scientific Basis for a Predictive Drug Test- Platform
11. Rigel Provides Clinical Update of R788 Phase 2 Trials in ITP, Rheumatoid Arthritis and Lymphoma
Post Your Comments:
(Date:5/23/2013)... y PARÍS, 24 de mayo de ... ), un destacado desarrollador y fabricante de herramientas ... la diagnosis y tratamiento de la enfermedad vascular ... del ensayo ADVISE ( Ad enosine V ... E valuation) II durante la sesión de ensayo ...
(Date:5/23/2013)... 23, 2013 Amgen (NASDAQ: AMGN ) ... Healthcare Conference on Thursday, May 30, 2013, at the Westin ... 9:20 a.m. Eastern Daylight Time. Arvind Sood ... at the conference. Live audio of the presentation can be ... , under Investors. A replay of the webcast will also ...
(Date:5/23/2013)... May 23, 2013 Nephros, Inc. (OTC Bulletin ... device company that develops and sells high performance liquid ... rights offering. In addition, the concurrent temporary reduction in ... on May 17, 2013. Nephros estimates that ... the rights offering. A portion of the proceeds will ...
Breaking Medicine Technology:Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 2Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 3Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 4Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 5Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 6Nephros Announces Completion of Rights Offering 2Nephros Announces Completion of Rights Offering 3Nephros Announces Completion of Rights Offering 4... , CRANBURY, N.J. , Feb. 1 ... producer in North America , today announced that it will host ... 10:00 am ET to discuss its fourth quarter and full ... will be issued on Wednesday, February 17, 2010 after market ...
... , , ... , WHAT: Each February, the American Dental Association (ADA) ... importance of oral health. Developing good habits at an early age ... on a lifetime of healthy teeth and gums. , (Logo: ...
Cached Medicine Technology:Innophos Holdings, Inc. Schedules Call to Discuss Fourth Quarter and Full Year 2009 Results 2Innophos Holdings, Inc. Schedules Call to Discuss Fourth Quarter and Full Year 2009 Results 3February is National Children's Dental Health Month -- 'Remember to Brush and Floss Every Day' is the Message -- Kids With Braces Need to be Extra Vigilant 2February is National Children's Dental Health Month -- 'Remember to Brush and Floss Every Day' is the Message -- Kids With Braces Need to be Extra Vigilant 3(Date:5/24/2013)... News) -- The number of U.S. patients admitted ... in an emergency room has increased by nearly ... study, conducted by researchers at the George Washington ... in Washington, D.C., found that patients wait five ... being admitted to the ICU. The researchers said ...
(Date:5/24/2013)... Bay, Australia (PRWEB) May 24, 2013 ... show off their favorite sunglasses all while learning ... longer with replacement lenses. Contestants only need ... wearing their sunglasses and "like" The Sunglass Fix ... winning Sunglass fix is the largest lens ...
(Date:5/24/2013)... aortic valve implantation (TAVI) is effective and safe in ... results from a multicentre Asian registry reported at EuroPCR ... a treatment option for selected patients with symptomatic severe ... North American or European centres," Paul Chiam, senior consultant ... conference. He explained that it is unknown whether the ...
(Date:5/24/2013)... In a coup that surely made other ... of the Estetica Institute of the Palm Beaches performed eye ... popular morning show, “The Mo & Sally Morning Show.” The ... satisfaction with the results, giving Dr. DeLange and the team ... Beach Gardens, very valuable free publicity. , Dr. DeLange, the ...
(Date:5/24/2013)... 2013 CBT News.com recently announced the addition ... web-based retail automotive industry news organization with 12 years experience ... to join a group that’s so forward-thinking in their approach,” ... online video content is on the rise.” , Atlanta born ... and segued into advertising at Cycle News and Boating World. ...
Breaking Medicine News(10 mins):Health News:Sharp Rise in ICU Admissions From U.S. Emergency Rooms 2Health News:Break the Sunglass Mold – Reuse 'Em, Don’t Toss 'Em then Enter the SunglassFIX Photo Contest to Win 2Health News:Registry confirms TAVI efficacy and safety in Asian patients 2Health News:Dr. Greg DeLange of the Estetica Institute Recently Performed Eye Surgery on Both Members of Popular Morning Radio Team 2[0] Sharp Rise in ICU Admissions From U.S. Emergency Rooms [0] Break the Sunglass Mold – Reuse 'Em, Don’t Toss 'Em then Enter the SunglassFIX Photo Contest to Win[0] Registry confirms TAVI efficacy and safety in Asian patients[0] Dr. Greg DeLange of the Estetica Institute Recently Performed Eye Surgery on Both Members of Popular Morning Radio Team[0] Tom Gonter to Drive Sales at Retail Automotive News Organization CBT News
... HealthDay Reporter , WEDNESDAY, July 27 (HealthDay News) ... emotional or behavioral issues often face tough social and ... , Tracking the progress of more than 1,450 students ... U.S. researchers found that one-third coped with special health ...
... research out of UCLA has found that Latinos living in ... the country are far less likely to spend for ... they do spend than the white population. ... they stay in the country, spending disparities remain large over ...
... discoveries in the field of cognitive neuroscience hold great ... a significant gap between such scientific discoveries and the ... New York Academy of Sciences and the ... conference on September 22-24, 2011 in Aspen, Colorado, ...
... BROOK, Ill. (July, 27, 2011) Using computed tomography (CT), ... lungs of patients with chronic obstructive pulmonary disease (COPD) that ... worsen. Their findings are published online in the journal ... the air sacs of the lungs, and is a leading ...
... risk factor for COPD, but have not accounted for ... Women,s Hospital, the University of Colorado, and National Jewish ... from the COPD Gene Study, capturing parental smoking and ... findings noted a strong risk factor for COPD when ...
... Brigham and Women,s Hospital (BWH) uses a new imaging technique, ... that are activated when patients with low back pain have ... published in the August issue of the journal Anesthesiology ... providing tools to objectively describe someone,s chronic pain which is ...
Cached Medicine News:Health News: Special Needs Kids Bullied More, Fare Poorly at School 2Health News: Special Needs Kids Bullied More, Fare Poorly at School 3Health News:Big gap exists on health care spending between Latinos and whites, study finds 2Health News:Conference: Improving K-12 education with cutting-edge cognitive neuroscience research 2Health News:CT shows changes in lungs associated with COPD flare-ups 2Health News:New imaging technique captures brain activity in patients with chronic low back pain 2 Special Needs Kids Bullied More, Fare Poorly at SchoolBig gap exists on health care spending between Latinos and whites, study findsConference: Improving K-12 education with cutting-edge cognitive neuroscience research CT shows changes in lungs associated with COPD flare-upsFamily history a risk factor for COPDNew imaging technique captures brain activity in patients with chronic low back pain
Anterior Chamber Needle, 30 g. Angled. 5 mm angled tip. Overall length 20 mm. 5/box....
Anterior Chamber Needle, 23 g. Angled. 7 mm angled tip. Overall length 23 mm. 5/box....
Anterior Chamber Needle, 20 g. Angled. 7 mm angled tip. Overall length 23 mm. 5/box....
Hydrodissection / Aspiration Cannula, 25 g. Angled with right hook. 10 mm angled shaft with 2.5 mm right hook tip. Overall length 20 mm. 5/box....
Medicine Products:| Copyright © 2003-2012 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |